Epigenetic Epidemiology
Editat de Karin B. Michelsen Limba Engleză Hardback – 3 ian 2012
With contributions from: Peter Jones, Jean-Pierre Issa, Gavin Kelsey, Robert Waterland, and many other experts in epigenetics!
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1362.82 lei 6-8 săpt. | |
Springer International Publishing – 16 apr 2023 | 1362.82 lei 6-8 săpt. | |
Hardback (2) | 1087.81 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 3 ian 2012 | 1087.81 lei 6-8 săpt. | |
Springer International Publishing – 15 apr 2022 | 1368.85 lei 6-8 săpt. |
Preț: 1087.81 lei
Preț vechi: 1145.07 lei
-5% Nou
Puncte Express: 1632
Preț estimativ în valută:
208.18€ • 216.25$ • 172.93£
208.18€ • 216.25$ • 172.93£
Carte tipărită la comandă
Livrare economică 04-18 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400724945
ISBN-10: 9400724942
Pagini: 457
Ilustrații: XII, 448 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:2012
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400724942
Pagini: 457
Ilustrații: XII, 448 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:2012
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
Introduction.-1. The Human Epigenome.-2. Considerations in the Design, Conduct, and Interpretation of Studies in Epigenetic Epidemiology.-3. Laboratory methods in epigenetic epidemiology.-4. Biostatistical methods in epigenetic epidemiology.-5. Epigenome changes during development.-6. The role of epigenetics in the developmental origins of health and disease.-7. Epigenetics and assisted reproductive technology.-8. Imprinting disorders of early childhood.-9. The utility of twins for epigenetic analysis.-10. Changes in the epigenetic profile with age.-11. Influence of environmental factors on the epigenome.-12. Epigenetic epidemiology of cancer.-13. Epigenetic epidemiology of infectious diseases.-14. Epigenetic epidemiology of inflammation and rheumatoid arthritis.-15. Asthma epigenetics: Emergence of a new paradigm? -16. Epigenetic epidemiology of autism and other neurodevelopmental disorders.-17. Epigenetic epidemiology of psychiatric disorders.-18. Epigenetic epidemiology of type 1diabetes.-19. Epigenetic epidemiology of obesity, type 2 diabetes, and metabolic disorders.-20. Epigenetic epidemiology of atherosclerosis. Index.
Recenzii
From the reviews:
“It aims to be both a primer in epidemiology for epigeneticists and an epigenetics reference for epidemiologists. … the field of epigenetic epidemiology is in ascendency and this textbook provides the first broad foundation for anyone embarking on population-based studies in epigenetic epidemiology. … Any prospective researcher aspiring to address any of the many unanswered fundamental issues in this field would certainly find this book a must useful reference.” (Catherine Potter and Caroline L. Relton, International Journal of Epidemiology, Vol. 41 (1), February, 2012)
“It aims to be both a primer in epidemiology for epigeneticists and an epigenetics reference for epidemiologists. … the field of epigenetic epidemiology is in ascendency and this textbook provides the first broad foundation for anyone embarking on population-based studies in epigenetic epidemiology. … Any prospective researcher aspiring to address any of the many unanswered fundamental issues in this field would certainly find this book a must useful reference.” (Catherine Potter and Caroline L. Relton, International Journal of Epidemiology, Vol. 41 (1), February, 2012)
Textul de pe ultima copertă
The exploding field of epigenetics is challenging the dogma of traditional Mendelian inheritance. Epigenetics plays an important role in shaping who we are and contributes to our prospects of health and disease. While early epigenetic research focused on plant and animal models and in vitro experiments, population-based epidemiologic studies increasingly incorporate epigenetic components. The relevance of epigenetic marks, such as DNA methylation, genomic imprinting, and histone modification for disease causation has yet to be fully explored. This book covers the basic concepts of epigenetic epidemiology, discusses challenges in study design, analysis, and interpretation, epigenetic laboratory techniques, the influence of of age and environmental factors on shaping the epigenome, the role of epigenetics in the developmental origins hypothesis, and provides the state of the art on the epigenetic epidemiology of various health conditions including childhood syndromes, cancer, infectious diseases, inflammation and rheumatoid arthritis, asthma, autism and other neurodevelopmental disorders, psychiatric disorders, diabetes, obesity and metabolic disorders, and atherosclerosis.
With contributions from: Peter Jones, Jean-Pierre Issa, Gavin Kelsey, Robert Waterland, and many other experts in epigenetics!
With contributions from: Peter Jones, Jean-Pierre Issa, Gavin Kelsey, Robert Waterland, and many other experts in epigenetics!
Caracteristici
First book in this new, emerging field State of the art on human evidence in epigenetics Helps to digest rapid growing information on epigenetics in humans A guide how to design a study on epigenetics in humans Assists in interpreting and understanding epigenetic evidence in humans
Notă biografică
Karin B. Michels is Professor and Chair of the Department of Epidemiology at the Fielding School of Public Health at UCLA. She received a ScD in Epidemiology from Harvard University and a PhD in Biostatistics from Cambridge University, UK. She was Assistant and Associate Professor at Harvard Medical School until she joined UCLA in 2016. Dr. Michels is a co-founder of the field of epigenetic epidemiology. Her work focusses on the early life origins of cancer, the role of nutrition in maintaining health, and the impact of the environment on the epigenome and the microbiome. She has published more than 300 peer-reviewed publications. Her work has been supported by the National Institutes of Health, the American Cancer Society, the Department of Defense, the Komen Foundation, and the Breast Cancer Research Foundation.